Activated PI3K results in phosphorylated phosphatidylinositides (PIP3), a step inhibited by product of the tumor suppressor gene, PTEN. Activating mutations of PIK3CA, the gene encoding PI3K, have been reported in a subset of pancreatic cancer precursors, specifically in IPMNs [71]. This evidence concerns the gene PIK3CA and pancreatic neoplasm.